Literature DB >> 16085442

Ochronotic rheumatism in Algeria: clinical, radiological, biological and molecular studies--a case study of 14 patients in 11 families.

Aicha Ladjouze-Rezig1, Santiago Rodriguez de Cordoba, Robert Aquaron.   

Abstract

OBJECTIVES: To confirm alkaptonuria and ochronotic arthropathy diagnosis by mutation screening of the homogentisate 1,2-dioxygenase (HGD) gene. Try to establish a genotype-phenotype correlation in the five subjects with a molecular study on HGD gene.
METHODS: We report 14 alkaptonuria cases (10 men and four women) in 11 Algerian families. Consanguineous matings were evidenced in only three families (F = 1/16). Molecular analysis was performed by sequencing genomic DNA in order to identify the mutations of the HGD gene.
RESULTS: Alkaptonuria was always confirmed by urinary homogentisic acid determination. Four different mutations of the HGD gene were found: an homozygous missense mutation, Serine189Isoleucine in two sisters with a mild phenotype; an homozygous splice site mutation (IVS1-1G > A) in a man with a severe phenotype (death at 61 years old from renal failure); a silent mutation, Alanine470Alanine at the heterozygous state in a man with a mild phenotype; a 'G' deletion at the position c.819 which causes a frameshift after Gly217(Gly217fs) that runs into a stop codon at c. 850. This mutation is novel and was found in heterozygosis in a woman with a mild phenotype.
CONCLUSIONS: The two homozygous mutations were associated, respectively, with a severe and a mild phenotype but no genotype-phenotype correlation could be found.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16085442     DOI: 10.1016/j.jbspin.2005.03.010

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  8 in total

1.  An update on molecular genetics of Alkaptonuria (AKU).

Authors:  Andrea Zatkova
Journal:  J Inherit Metab Dis       Date:  2011-07-01       Impact factor: 4.982

2.  Nine cases of Alkaptonuria in one family in southern Jordan.

Authors:  Mohammed Al-Sbou; Nesrin Mwafi
Journal:  Rheumatol Int       Date:  2010-12-03       Impact factor: 2.631

Review 3.  Alkaptonuria in France: past experience and lessons for the future.

Authors:  Robert Raphael Aquaron
Journal:  J Inherit Metab Dis       Date:  2011-09-17       Impact factor: 4.982

4.  Bisphosphonate treatment in ochronotic osteoporotic patients.

Authors:  Giuseppe Aliberti; Isabella Pulignano; Daniela Pisani; Massimiliano Rocchietti March; Flavia Del Porto; Maria Proietta
Journal:  Clin Rheumatol       Date:  2006-08-19       Impact factor: 2.980

5.  Mutation spectrum of homogentisic acid oxidase (HGD) in alkaptonuria.

Authors:  Thierry Vilboux; Michael Kayser; Wendy Introne; Pim Suwannarat; Isa Bernardini; Roxanne Fischer; Kevin O'Brien; Robert Kleta; Marjan Huizing; William A Gahl
Journal:  Hum Mutat       Date:  2009-12       Impact factor: 4.878

6.  A case of ochronosis with gout and Monckeberg arteries.

Authors:  Hadi Karimzadeh; Negin Mohtasham; Mansoor Karimifar; Mansour Salesi; Zahra Sayed Bonakdar
Journal:  Rheumatol Int       Date:  2009-02-27       Impact factor: 2.631

7.  Impact of chronic kidney disease on the natural history of alkaptonuria.

Authors:  Bernardo Faria; Joana Vidinha; Cátia Pêgo; Hugo Correia; Tânia Sousa
Journal:  Clin Kidney J       Date:  2012-08

Review 8.  On the ocular findings in ochronosis: a systematic review of literature.

Authors:  Moritz Lindner; Thomas Bertelmann
Journal:  BMC Ophthalmol       Date:  2014-01-30       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.